000 | 01978 a2200565 4500 | ||
---|---|---|---|
005 | 20250514003553.0 | ||
264 | 0 | _c20010802 | |
008 | 200108s 0 0 eng d | ||
022 | _a0002-9343 | ||
024 | 7 |
_a10.1016/s0002-9343(01)00713-6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKipnes, M S | |
245 | 0 | 0 |
_aPioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. _h[electronic resource] |
260 |
_bThe American journal of medicine _cJul 2001 |
||
300 |
_a10-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 |
_aC-Peptide _xblood |
650 | 0 | 4 |
_aCholesterol, HDL _xblood |
650 | 0 | 4 |
_aCholesterol, LDL _xblood |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
650 | 0 | 4 |
_aInsulin _xblood |
650 | 0 | 4 |
_aLipids _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPioglitazone |
650 | 0 | 4 |
_aSulfonylurea Compounds _xadministration & dosage |
650 | 0 | 4 |
_aThiazoles _xadministration & dosage |
650 | 0 | 4 | _aThiazolidinediones |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTriglycerides _xblood |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aKrosnick, A | |
700 | 1 | _aRendell, M S | |
700 | 1 | _aEgan, J W | |
700 | 1 | _aMathisen, A L | |
700 | 1 | _aSchneider, R L | |
773 | 0 |
_tThe American journal of medicine _gvol. 111 _gno. 1 _gp. 10-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9343(01)00713-6 _zAvailable from publisher's website |
999 |
_c11377215 _d11377215 |